Compare Organon Pharma Indonesia Tbk. (SCPI) vs Sidomulyo Selaras Tbk. (SDMU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Sidomulyo Selaras Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sidomulyo Selaras Tbk. trades at Rp90 (market cap 202.56B, 10.05M 24h volume). The key difference: Sidomulyo Selaras Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| SCPI | SDMU | |
|---|---|---|
Market Cap | 104.4B | 202.56B |
Volume | — | 10.05M |
Lot | — | 100.53K |
Turnover | — | 884.89M |
Average Price | — | 88.02 |
Value | — | 884.89M |
Indicative Equilibrium Price | — | 90 |
Indicative Equilibrium Volume | — | 614 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Sidomulyo Selaras Tbk.
Sidomulyo Selaras Tbk (the company) was established on 13 Dec 1993 based on Notaries Deed No. 42 and the deed of establishment was approved by the the Ministry of Justice dated Feb 10, 1994. The Company’s articles of association has been amended several times, most recently by notarial deed No. 12 of F.Y Wijaya, S.H., dated Feb 28, 2011.
Read more on SDMU →
